Press Releases

EIN Presswire

New Certification Program in Clinical Patient Care Leadership Announced by The American Institute of Health Care Professionals, Inc. WARREN, OH, UNITED STATES, May 18, 2026 /⁨EINPresswire.com⁩/ -- The American Institute of Health Care...

GlobeNewswire, Inc.

Washington, D.C., May 18, 2026 (GLOBE NEWSWIRE) -- Animal Wellness Action and the Center for a Humane Economy today urged Major League Baseball (MLB) to investigate LA Dodgers pitcher Edwin Diaz for illegal cockfighting activity in Puerto Rico and...

GlobeNewswire, Inc.

Key highlights from the first quarter of operations under the expanded management team include the following: Anticipated FDA decision on the Company's ANDA for Preservative-Free Ketamine in Q3 2026, with favorable preliminary determinations...

EIN Presswire

Annual competition of major clinical research breakthroughs illustrates the return on the nation's investment in the health and welfare of its citizens.

GlobeNewswire, Inc.

Federal Officials, Researchers, Clinicians and Biopharma Leadership Convened by Psychedelic Medicine Coalition at the National Press Club Vancouver, Canada, May 15, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or...

GlobeNewswire, Inc.

Data reinforce WVE-006’s potential to address both lung and liver manifestations of AATD with a durable, convenient, and safe therapy capable of recapitulating the protective MZ-like phenotype with monthly dosing On track for feedback from FDA on...

GlobeNewswire, Inc.

Washington, D.C., May 18, 2026 (GLOBE NEWSWIRE) -- Blue Star Families, in collaboration with The Walt Disney Company, hosted a special Blue Star Books event at the Library of Congress in Washington, D.C. on Sunday, bringing together more than 500...

GlobeNewswire, Inc.

Bio-Hermes-002 is a collaborative study focused on new biomarkers designed to improve diagnosis of Alzheimer's disease and dementias WASHINGTON, D.C., May 18, 2026 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to...

GlobeNewswire, Inc.

Washington, D.C., May 18, 2026 (GLOBE NEWSWIRE) -- The Personal Care Products Council (PCPC) today released its latest economic impact report, Beyond Beauty: Economic Impact of the U.S. Personal Care Products Industry, which highlights the...

GlobeNewswire, Inc.

Miami, May 18, 2026 (GLOBE NEWSWIRE) -- Muck Rack, the AI communications platform, today announced a new content partnership with STAT, the leading media company covering the business of medicine, health tech, science and public health.

EIN Presswire

Our advanced diagnostic program finds hidden issues before treatment—sperm DNA analysis, BCL6 testing, bacteriology, and genetic screening for both partners.

GlobeNewswire, Inc.

CAMBRIDGE, Mass., May 15, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA®) platform to develop a new class of genetic medicines for...

GlobeNewswire, Inc.

WASHINGTON, May 15, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, today reported its financial results for the...

GlobeNewswire, Inc.

LANHAM, Md., May 18, 2026 (GLOBE NEWSWIRE) -- Verbal Beginnings, a leading provider of comprehensive autism services, is pleased to announce the opening of a new Early Intervention center in Lanham, Maryland.

GlobeNewswire, Inc.

NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- Garfunkel Wild, P.C. is pleased to announce that Steven E. Frankel, an accomplished litigator, has joined the firm as a partner in its Garden City, New York office serving in the firm’s Litigation and...

GlobeNewswire, Inc.

Completed enrollment in first cohort of Phase 1b challenge study evaluating CDI-988 as a preventive and as a treatment for norovirus infection, began enrollment in prevention and treatment cohorts Highlighted CDI-988’s mechanism of action and...

GlobeNewswire, Inc.

Company to continue development of efzofitimod in pulmonary sarcoidosis following Type C meeting with the FDA. Company plans to submit an IND in June 2026 for a Phase 3 study of efzofitimod in patients with chronic, symptomatic pulmonary...

Georgia Office of the Governor

ATLANTA - Governor Brian P. Kemp, joined by First Lady Marty Kemp and Office of Planning and Budget (OPB) Director Rick Dunn, today signed the state budget for Fiscal Year 2027. Below is an excerpt of the governor's remarks which includes a link...

GlobeNewswire, Inc.

Data Supported the FDA Approval of the Zenflow Spring® Implant and Delivery System for BPH Additional presented data highlights patient satisfaction & long-term safety SOUTH SAN FRANCISCO, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Zenflow, Inc....

EIN Presswire

Proprietary Gene Therapies, XPRIZE Finalist BRAIN RESET Protocol, and Bespoke Stem Cell Treatments Now Available in the Heart of The Bahamas PARADISE ISLAND, BAHAMAS, May 14, 2026 /⁨EINPresswire.com⁩/ -- GARM Bahamas Ltd. is proud to announce the...